Officials from the European Union (EU) and India are expected to meet in Brussels on April 12th to resume technical talks on the long-stalled EU-India free trade agreement (FTA). A leaked draft of the agreement, which has been under discussion since 2007, contains proposals from the EU that push for intellectual property (IP) provisions in … Read more
India’s Ministry of Health recently released the “Report of the First National Anti-Tuberculosis Drug Resistance Survey”. According to the report, the survey is the largest national drug-resistant (DR) TB survey ever conducted by any country in the world. The survey results reveal that more than 6% of all TB patients in India have multidrug-resistant TB … Read more
Doctors Without Borders/Médecins Sans Frontières (MSF) urges Pfizer to drop unmerited patents that hinder access to lifesaving childhood vaccine worldwide New York/Seoul —The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) has filed a legal petition to the Supreme Court of South Korea requesting to review the patent granted to US pharmaceutical corporation Pfizer for … Read more
Gilead recently launched one of these drugs for $100/pill in China Geneva, 18 December 2017 – The international medical humanitarian organisation Doctors Without Borders/Médecins Sans Frontières (MSF) has filed a legal patent challenge in China against US pharmaceutical corporation Gilead’s patent application for the combination of two crucial oral hepatitis C medicines, sofosbuvir and velpatasvir. This … Read more
At High Court of Delhi hearing tomorrow, Doctors Without Borders/Médecins Sans Frontières (MSF) will urge India to remain the “pharmacy of the developing world” and rethink decision that solidifies Pfizer monopoly on critical pneumonia vaccine New York/ New Delhi, November 20, 2017 — Pfizer does not deserve the patent it was granted in August on its pneumonia vaccine … Read more
Dramatic price drops should allow countries to provide treatment for millions of people Geneva/Sao Paolo — On the eve of the World Hepatitis Summit in Sao Paolo, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today announced that it had secured deals for generic hepatitis C medicines for as low as US$1.40 per … Read more
New Delhi, 13 October 2017 – Médecins Sans Frontières/Doctors Without Borders India has filed a petition before the High Court of Delhi to overturn the patent granted on the pneumococcal conjugate vaccine (PCV) to the US pharmaceutical corporation Pfizer. Earlier this year, on August 13, the Indian Patent Office dashed hopes for improved access to … Read more
Geneva/New York/New Delhi, 22 August 2017 – Hopes for improved access to an affordable pneumococcal conjugate vaccine (PCV) that safeguards both children and adults from pneumonia were dealt a major blow after the Indian patent office granted a patent to the US pharmaceutical corporation Pfizer for its PCV13 product, marketed as Prevnar13. “It’s unfair and … Read more
Hyderabad, July 21, 2017 – As negotiators for the Regional Comprehensive Economic Partnership (RCEP) trade agreement meet for another round of negotiations in Hyderabad next week, networks of people living with HIV/AIDS from different parts of the country, public health experts from the region and Doctors Without Borders/Médecins Sans Frontières (MSF) will mobilise in the city to … Read more
New York/New Delhi, June 26, 2017 – As U.S. President Donald Trump and Indian Prime Minister Narendra Modi meet at the White House today, Doctors Without Borders/Médecins Sans Frontières (MSF) warned that U.S. pressure on India to change its drug regulatory and patent system could result in millions of people in the U.S. and around the world losing … Read more